Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
Altogen/MCF-7 Transfection Reagent (Breast Cancer, HTB-22)/0.5 ml(Catalog #1765)188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Altogen/MCF-7 Transfection Reagent (Breast Cancer, HTB-22)/0.5 ml(Catalog #1765)

Description

ProductAvailABIlity:InStock(deliverywithin2-3businessdays,noextrachargefordrop-shipping).

Ordering:ToplaceanorderviacreditcardorPOuseAddtoCartbutton(creatinganaccountisnotrequired).


TransfectionReagentfor MCF-7Cells(BreastCancerCells,HTB-22)

  • Proprietarycationiclipidformulation
  • HightransfectionefficiencyofsmallRNA(siRNA,shRNA,miRNA),mRNA,andplasmidDNA
  • Effectiveandrobustintracellulardelivery
  • Work inthepresenceofserum
  • Aprovenreagentforestablishingstablecelllines
  • Optimizedtransfectionprotocolsareadaptedforusewithbothstandard&reversetransfectionmethods
  • Download MCF-7transfectionprotocol:[PDF]
  • Download MCF7CRISPR/Cas9transfectionprotocol:[PDF]
  • DownloadPowerPointpresentationforMCF-7 cellstransfectionkit:[PPT]
  • DevelopedandmanufacturedbyAltogenBiosystems

TransfectionEfficiency:

Reagentexhibitsatleast85%transfectionefficiencyofsiRNAdelivery.TransfectionefficiencywasdeterminedbyqRT-PCR.

TransfectionProtocolandMSDS:

DownloadAltogenBiosystemsMCF-7TransfectionProtocol:[PDF]

DownloadMSDS:[PDF]

MCF-7 CellLine:

BreastcancerremainsthesecondprimarycauseofcancerdeathsinfemalesaswellasthemostcommonlydiagnosedcancerinwomenintheUnitedStates.AccordingtotheNationalBreastCancerFoundation,everyyearmorethan252,000womeninthecountryarediagnosedwithbreastcancerandover40,000willdie.TheMCF-7celllinewasderivedfroma69-year-oldCaucasianfemalein1970andisthemostextensivelystudiedandfrequentlyusedofallthehumanbreastcancercelllines.MCF-7standsforMichiganCancerFoundation–7(referringtotheinstitutewherein1973thecelllinewasdiscoveredbySouleandassociates).Thiscelllineisaperfectmodeltostudythepathwayofmalignantprogression.PrevioustoMCF-7,nomammarycelllinecouldlivelongerthanafewmonths.MCF-7hasmultiplecharacteristicsofdifferentiatedmammaryepithelium,includingthecapabilityofformingdomesandtheabilitytoprocessestrADIolviacytoplasmicestrogenreceptors.TNFalphainhibitsthegrowthofMCF-7breastcancercells.Applyinganti-estrogenscantransformthesecretionofinsulin-likegrowthfactorbindingproteins.CellsfromtheMCF-7breastcancercelllinearewidelyregardedasanearperfectmodeltoexaminethegrowthofmalignanttumors.AltogenBiosystemsproducespre-optimizedhigh-efficiencytransfectionreagentkitsfortheMCF-7breastcancercellline.

Data:

Figure1.GAPDmRNAlevelswerequantifiedusingreal-timeRT-PCRintheMCF7cellstransfectedwithsiRNAstargetingGAPDornon-silencingsiRNA.Forty-eighthourspost-transfection,thecellswereharvestedandanalyzedbyreal-timeRT-PCRforGAPDHmRNAexpressionlevels.Datawerenormalizedagainstthe18SrRNAsignal.Controlsampleswereeithermock-transfectedoruntreated.Valuesarenormalizedtountreatedsample.Dataaremeans±SD(n=3).

MCF7-cells-transfection-protocol

Figure2.ProteinexpressionofGAPDHinMCF7cells.DNAplasmidexpressingGAPDHorsiRNAtargetingGAPDHweretransfectedintoMCF7cellsfollowingAltogenBiosystemstransfectionprotocol.At72hourspost-transfectionthecellswereanalyzedbyWesternBlotforproteinexpressionlevels(normalizedbytotalprotein,10µgoftotalproteinloadedpereachwell).Untreatedcellsusedasanegativecontrol.

 

Selected MCF7 transfectionreagentcitationreferences:

  • BMCCancer.(2017)17:169.Alteringcalciuminfluxforselectivedestructionofbreasttumor.Yuetal[PDF]
  • J TranslMed.201015;8:133.Preventionofhyperglycemia-inducedmyocardialapoptosis…Zhangetal[PDF]

RequestaQuotefor
MCF-7TransfectionReagent

AltogenBiosystems:
AltogenBiosystemsisalifesciencescompany thatmanufacturesover100celltypespecificandpre-optimizedtransfection kits, electroporationbuffers,andtargetedinvivo deliverykitsandreagents.Advancedformulationofreagentsandoptimizedtransfectionprotocolsprovidehighlyefficientintracellulardeliveryofbiomolecules(proteins,DNA,mRNA,shRNA andsiRNA,andsmallmoleculecompounds).Readmore abouttransfectiontechnologyatAltogen’s TransfectionResource.

AltogenLabsResearchServices:

AltogenLabsprovidesGLP-compliantcontractresearchstudiesforpre-clinicalresearch,INDapplications,anddrugdevelopment.OurBIOLOGyCROservices include:Xenograftservices(over60in-housevalidatedxenograftmodels),developmentofstablecelllines,ELISAassaydevelopment,cell-basedandtissuetargetedRNAistudies,safetypharm/toxassays,andotherstudies(visitAltogenLabs.com).

VolumeOptions:

  • 0.5ml(Catalog#1765)
  • 1.5ml(Catalog#1766)
  • 1.5mlCRISPR(Catalog#2169)
  • 8.0ml(Catalog#7059)
新闻动态
行业前沿
技术文章
最新产品